Company Metrics
LIXT Bitcoin Exposure
LIXT Valuation Metrics
LIXT Stock Returns
LIXT Trading & Risk
LIXT Options
About LIXTE Biotechnology's Bitcoin Treasury Strategy
LIXTE Biotechnology (LIXT) ranks #148 globally among Bitcoin treasury companies, with 10.5 Bitcoin in its corporate treasury worth approximately $723.04K at current prices. This represents 0.000% of the total 21 million Bitcoin that will ever exist.
Trading at a stock price of $2.86 per share with a market capitalization of $24.89M, LIXTE Biotechnology's stock currently trades at an mNAV (enterprise value to Bitcoin NAV multiple) of 30.43x. Bitcoin holdings represent 3% of the company's market cap, underscoring Bitcoin's central role in LIXTE Biotechnology's balance sheet strategy.
LIXTE Biotechnology currently trades -54.31% from its 52-week high. The stock averages β in daily trading volume over the past 30 days, with 30-day volatility at β.